Average Co-Inventor Count = 4.96
ph-index = 18
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (28 from 666 patents)
2. Incyte Holdings Corporation (10 from 147 patents)
3. Prelude Therapeutics Incorporated (3 from 18 patents)
4. Prelude Therapeutis Incorporated (1 from 1 patent)
32 patents:
1. 12486277 - CDK inhibitors and their use as pharmaceuticals
2. 12448389 - BRM targeting compounds and associated methods of use
3. 11840534 - Substituted tricyclic compounds as FGFR inhibitors
4. 11702423 - BRM targeting compounds and associated methods of use
5. 11673893 - CDK inhibitors and their use as pharmaceuticals
6. 11673883 - Heterocyclic compounds as immunomodulators
7. 11667635 - Bicyclic heterocycles as FGFR4 inhibitors
8. 11530214 - Bicyclic heterocycles as FGFR inhibitors
9. 11053246 - Substituted tricyclic compounds as FGFR inhibitors
10. 11014923 - Bicyclic heterocycles as FGFR4 inhibitors
11. 10851105 - Bicyclic heterocycles as FGFR4 inhibitors
12. 10806785 - Immunomodulator compounds and methods of use
13. 10738048 - Bicyclic heterocycles as FGFR4 inhibitors
14. 10640503 - Imidazopyridines and imidazopyrazines as LSD1 inhibitors
15. 10556908 - Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors